Published Paper Details:

Artificial intelligence (AI) has developed into a useful technology that makes use of human expertise and provides speedier solutions for challenging issues. Significant advancements in AI and machine learning technology have the potential to revolutionize the drug discovery process. the creation and assessment of drug dose formulations. By leveraging a plethora of biological data, including proteomics and genomes, artificial intelligence systems enable scientists to forecast the relationships between putative therapeutic candidates and targets linked to disease. As a result, drug discovery can be approached with greater effectiveness and attention, increasing the likelihood of a successful medication authorization. The possible ways in which artificial intelligence (AI) could improve the efficiency of the process of developing new pharmaceutical products and the collaboration between the main players in the pharmaceutical industry and AI-powered drug research companies. This evaluation focuses on the advantages and disadvantages of the various AI-based pharmaceutical technology techniques. Ongoing research and investment in artificial intelligence by the pharmaceutical business, however, offers exciting prospects for methods of product creation.